BARICITINIB | BARICITINIB | ATC L04AF02
IMMUNOMODULATING JANUS KINASES (JAKS) INHIBITOR TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS | ORAL | Tmax 1 HOUR F 80 PERCENT VD 76 LITER PPB 50 PERCENT Cl 8.9 LITER / HOUR HT 12 HOUR | JANUS KINASES (JAK) PDB 4W9X (CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH BARICITINIB) LIGAND CODE = 3JW (link to the list of PDB complexes) Download experimental 3D coordinates of 3JW with added hydrogens | Tyrosine-protein kinase JAK1 UNIPROT P23458 JAK1 -- Tyrosine-protein kinase JAK2 UNIPROT O60674 JAK2 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |